Florian Preinfalk

Getting Ready For The EU Pharma Package Part 2: Stricter Rules On Environmental Risk Assessment – Everything You Need To Know

Getting Ready For The EU Pharma Package: Key Changes To Regulatory Exclusivities, Orphan Medicinal Products And The “Bolar” Exemption Provisions

EU Commission Proposes Much Anticipated MDR And IVDR Revision

EU Pharma Package: Parliament And Council Reach Agreement To Modernize EU Pharmaceutical Legislation—Key Takeaways For Pharma

EU Restricts Chinese Access To Public Procurement Of Medical Devices

New German Government: Key Plans For The Life Sciences And Healthcare Sector

New CJEU Ruling On The Borderline Between Medicinal Products And Medical Devices: Key Takeaways

Key Regulatory Changes Impacting The Healthcare Industry In The EU And Germany In 2025